Absorica Ld Capsule
Product Images NDC 10631-005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Absorica Ld (NDC 10631-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Absorica 02)
Blister 10mg (Absorica 03)
Carton-10mg (Absorica 04)
Blister 20mg (Absorica 05)
Carton 20mg (Absorica 06)
Blister 25mg (Absorica 07)
Carton 25mg (Absorica 08)
Blister 30mg (Absorica 09)
Carton 30mg (Absorica 10)
Blister 35mg (Absorica 11)
Carton 35mg (Absorica 12)
Blister 40mg (Absorica 13)
Carton 40mg (Absorica 14)
Absorica Ld-8mg-carton (Absorica 16)
Absorica Ld-16mg-carton (Absorica 18)
Pdp-24 mg Carton (Absorica 20)
Pdp-32mg Carton (Absorica 22)
This text appears to be a medication label or prescription information. The medication is called "AbsoricalD" and comes in the form of capsules containing 32mg of isotretinoin, USP. The label warns that the medication is contraindicated in pregnancy and should be dispensed with an enclosed medication guide. There are also reminders for pharmacists regarding the packaging and storage of the medication.*
Spl Absorica Ld 16 mg Wallet
Spl Absorica Ld 24 mg Wallet
Spl Absorica Ld 32 mg Wallet
Spl Absorica Ld Wallet 8 mg
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.